In a new study, researchers have targeted TANGO2, an iron-rich blood molecule, to investigate its role in health and disease.
The study, published in the journal Nature Medicine, used a technique called proteomics to identify TANGO2 as a potential target for blood disorders.
Proteomics is a method of studying proteins, their function and their interactions with other proteins.
In this study, the researchers used proteomics to identify TANGO2 as a potential target for blood disorders.
They found that TANGO2 is a highly abundant protein in the blood and is involved in the transport of iron.
Iron is an essential mineral for many processes in the body, including the production of red blood cells.
However, too much iron can be toxic and can cause problems such as heart disease and cancer.
The researchers believe that TANGO2 may be involved in regulating iron levels in the blood and could be a potential target for the treatment of iron-related disorders.
This study is the first to identify TANGO2 as a potential target for blood disorders and provides a new target for further research.
A new study has found that the iron-rich blood molecule TANGO2 may be a potential target for treating conditions associated with iron overload.
Iron is an essential nutrient for many processes in the body, but too much iron can be harmful. Iron overload can lead to conditions such as liver disease, heart failure, and diabetes.
If you have too much iron in your blood, it can bind to and damage tissues and organs. This can lead to inflammation and cell death.
The new study, published in the journal Nature Communications, identified TANGO2 as a potential target for treating iron overload.
TANGO2 is a protein that helps to transport iron in the blood. The researchers found that when TANGO2 was inhibited in mice, it led to a reduction in iron levels in the blood.
The study’s lead author, Dr. Ana J. Moore, said that the findings could lead to new treatments for conditions associated with iron overload.
“If we can target TANGO2, we may be able to reduce the amount of iron in the blood and, as a result, improve the health of patients with conditions like hemochromatosis,” said Dr. Moore.
Hemochromatosis is a condition that causes the body to absorb too much iron. It is a genetic disorder that can be passed down from parents to children.
If left untreated, hemochromatosis can lead to serious health problems, including liver disease, heart disease, and diabetes.
There is currently no cure for hemochromatosis, but treatment can help to manage the condition and prevent complications.
The new study provides hope that TANGO2 could be targeted to develop new treatments for iron overload and conditions like hemochromatosis.
